Bioregenx (BRGX) Change in Account Payables (2022 - 2026)
Bioregenx (BRGX) recorded quarterly Change in Account Payables of $82984.0 in Q1 2026, down 46.92% quarter-over-quarter from $156339.0 in Q4 2025, and up 16.83% on a YoY basis from $71032.0 in Q1 2025.
Bioregenx (BRGX) Change in Account Payables (2022 - 2026) Analysis & Trends
Bioregenx's Change in Account Payables history runs 5 years deep, the most recent figure standing at $82984.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 16.83% year-over-year to $82984.0; the TTM figure through Mar 2026 stood at $200464.0 (up 57.04% YoY), while the FY2025 annual figure was $188512.0, up 1.47% from the prior year.
- Change in Account Payables was $82984.0 for Q1 2026 at Bioregenx, down from $156339.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $317462.0 in Q3 2023 to a low of -$270713.0 in Q2 2023.
- Historically, Change in Account Payables has averaged $28488.3 across 5 years, with a median of $6916.0 in 2022.
- Biggest YoY gain for Change in Account Payables was 11107.7% in 2023; the steepest drop was 20347.79% in 2023.
- A 5-year view of Change in Account Payables shows it stood at $2355.0 in 2022, then surged by 3686.33% to $89168.0 in 2023, then soared by 147.46% to $220653.0 in 2024, then declined by 29.15% to $156339.0 in 2025, then plunged by 46.92% to $82984.0 in 2026.
- The last three Change in Account Payables figures came in at $82984.0 (Q1 2026), $156339.0 (Q4 2025), and -$109148.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 4.47 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | -86.99 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 4.78 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -16.25 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 16.18 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 82,984.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82,984.00 |
| Mar 31, 2026 | 82,984.00 |
| Dec 31, 2025 | 156,339.00 |
| Dec 31, 2025 | 156,339.00 |
| Sep 30, 2025 | -109,148.00 |
| Sep 30, 2025 | -109,148.00 |
| Jun 30, 2025 | 70,289.00 |
| Jun 30, 2025 | 70,289.00 |
| Mar 31, 2025 | 71,032.00 |
| Mar 31, 2025 | 71,032.00 |
| Dec 31, 2024 | 220,653.00 |
| Dec 31, 2024 | 220,653.00 |
| Sep 30, 2024 | -17,870.00 |
| Sep 30, 2024 | -17,870.00 |
| Jun 30, 2024 | -146,161.00 |
| Jun 30, 2024 | -146,161.00 |
| Mar 31, 2024 | 129,162.00 |
| Mar 31, 2024 | 129,162.00 |
| Dec 31, 2023 | 89,168.00 |
| Dec 31, 2023 | 89,168.00 |